The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of post-discharge symptom monitoring on hospital readmissions: A randomized trial.
 
Robert Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Jun Mao
No Relationships to Disclose
 
Jennifer Cracchiolo
Honoraria - Medscape
 
Jessie Holland
No Relationships to Disclose
 
Jennie Huang
No Relationships to Disclose
 
AnnMarie Mazzella Ebstein
No Relationships to Disclose
 
Chasity Walters
No Relationships to Disclose
 
Jill Ackerman
No Relationships to Disclose
 
Nitya Raj
Consulting or Advisory Role - Crinetics Pharmaceuticals
Speakers' Bureau - ITM Oncologics
Research Funding - Camarus AB (Inst); Corcept Therapeutics (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Camurus
 
Rachel Sanford
No Relationships to Disclose
 
Mark Dickson
Research Funding - AADi (Inst); Lilly (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
 
Alison Moskowitz
Honoraria - Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Kyowa Kirin International; Merck; Pfizer; Takeda
Research Funding - ADC Therapeutics (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Secura Bio (Inst)
 
Raajit Rampal
Honoraria - Protagonist Therapeutics
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Disc Medicine; Galecto; Incyte; Karyopharm Therapeutics; Novartis; Pharmaessentia; Promedior; SERVIER; Sierra Oncology; Stemline Therapeutics; Sunimoto Dainippon; Zentalis
Research Funding - Constellation Pharmaceuticals; Ryvu Therapeutics; Stemline Therapeutics; Zentalis
Travel, Accommodations, Expenses - Incyte; Sierra Oncology
 
Alexander Shoushtari
Consulting or Advisory Role - Erasca, Inc; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); IDEAYA Biosciences (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Mural Oncology (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
William Tew
No Relationships to Disclose
 
Martin Voss
Consulting or Advisory Role - Affimed Therapeutics; AstraZeneca; AVEO; Eisai; Exelixis; Merck; Oncorena
Research Funding - Exelixis; Pfizer; Regeneron
(OPTIONAL) Uncompensated Relationships - Aravive; AstraZeneca; BMS; Genentech/Roche; NiKang Therapeutics
 
Raymond Baser
No Relationships to Disclose
 
Peter Stetson
No Relationships to Disclose
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; EyePoint Pharmaceuticals (I); Kyverna Therapeutics (I); Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - AACR Project GENIE; The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Deb Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - Genentech; JAMA-Journal of the American Medical Association
Research Funding - AACR (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.